Seno Medical’s Next-Generation Imagio® Imaging System Obtains European Union (EU) Medical Device Regulation (MDR) CE Mark Certification
The CE Mark certification enables Seno Medical to market and sell the latest version of its Imagio® Imaging System with opto-acoustic, sound, and artificial intelligence in the European Union. Contact: Alex Hamlow, (210) 615-6501, ahamlow@senomedical.com [SAN ANTONIO, TX – 26-January-2026] Seno Medical has received CE Mark certification for its next-generation Imagio® Imaging System, Model 9100. […]
Seno Medical® Receives Innovative Technology Contract from Vizient For its Imagio® Breast Imaging System
Contract awarded for products that bring improvement to healthcare industry [SAN ANTONIO, TX – November 12, 2024]– Seno Medical announced its Imagio® Breast Imaging System has received an Innovative Technology contract from Vizient, Inc. the nation’s largest provider-driven healthcare performance improvement company. The contract was awarded based on the recommendation of the Imagio® System by […]
Real World Use of OA Imaging Confirms Clinical Acceptability of Second Generation Imagio® Breast Imaging System
[SAN ANTONIO, TX – October 31, 2024] A study published in Academic Radiology, Exploring the Utility of Optoacoustic Imaging in Differentiation of Benign and Malignant Breast Masses: Gen 2 Study, confirms that the second generation of Seno Medical’s Imagio® Breast Imaging System, which combines light, sound, and artificial intelligence (AI), is equal to or superior to the […]
IHE SHARAZONE Hits Major Milestone with 15 Participants, Empowering 37 Creators and 24 Consumers
[May 17, 2024] IHE-Europe is thrilled to report a major milestone for the IHE SHARAZONE, a groundbreaking initiative aimed at boosting digital interoperability and the exchange of health information. This innovative platform now proudly supports 15 participating organizations, each committed to enhancing the standardization of healthcare technologies, comprising 37 creators and 24 consumers systems with […]
American Medical Association Issues New CPT Code for Use of Seno Medical’s Opto-acoustic Technology in Breast Cancer Diagnosis
CPT Code 0857T Enables a Pathway for Reimbursement When Using Seno’s Imagio® Breast Imaging System to Diagnose Breast Cancer. [San Antonio, TX — February 13, 2024] The American Medical Association (AMA) has issued a new Category III Current Procedural Terminology (CPT*) code for the use of Imagio® (OA/US) Breast Imaging System, a new modality in breast cancer imaging and […]
Seno Medical Earns Frost & Sullivan’s 2023 United States Enabling Technology Leadership Award for Delivering a More Efficient Breast Cancer Diagnosis with Its Cutting-edge Technology
Seno Medical offers highly differentiated opto-acoustic/ultrasound (OA/US) exam to diagnose breast cancer and significantly reduce unnecessary breast biopsies. San Antonio, TX — January 17, 2024 — Frost & Sullivan recently recognized Seno Medical with the 2023 US Enabling Technology Leadership Award. Seno Medical is a groundbreaking company founded in 2005 that revolutionized the breast cancer imaging sector with its innovative […]
Study Finds Opto-Acoustic Imaging During Neoadjuvant Therapy Correlates to Pathologic Response
Study evaluates feasibility of leveraging Seno’s Imagio® System to detect response earlier during breast cancer therapy. [San Antonio, TX – December 8, 2023] A limited feasibility study presented at this year’s San Antonio Breast Cancer Symposium (SABCS) found that Seno Medical’s Imagio® Breast Imaging System using opto-acoustic/ultrasound (OA/US) shows promise in detecting vessel and oxygenation changes preceding tumor […]
Study Finds Opto-Acoustic Imaging Provides Significant Cost Benefits When Compared to Ultrasound Alone in Evaluation of Breast Lesions
Imagio® System’s unique hybrid modality helps doctors better characterize suspicious breast lesions to avoid unnecessary invasive biopsies and improve patient care. [San Antonio, TX – November 30, 2023] A study presented at RSNA and published in Academic Radiology has found that Seno Medical’s Imagio® Breast Imaging System with opto-acoustic ultrasound (OA/US) imaging is more cost effective when compared to […]
Alex Hamlow Joins Seno Medical as Chief Revenue Officer
[SAN ANTONIO, TX – SEPTEMBER 22, 2023] Alex Hamlow has joined Seno Medical Instruments, Inc. as Chief Revenue Officer. Seno Medical is the leader in improving the process of diagnosing breast cancer and the pioneer of the Imagio® Breast Imaging System with opto-acoustic/ultrasound (OA/US) imaging technology. Hamlow has over 20 years of experience in the healthcare […]
Seno Medical Adds Agnes Berzsenyi to Board of Directors
[SAN ANTONIO, TX – SEPTEMBER 14, 2023] Seno Medical Instruments, Inc., the leader in improving the process of diagnosing breast cancer and the pioneer of the Imagio® Breast Imaging System with opto-acoustic/ultrasound (OA/US) imaging technology, has added Agnes Berzsenyi to its Board of Directors, effective immediately. Ms Berzsenyi spent over 27 years at General Electric, where […]